--- title: "三博脑科医院管理集团股份有限公司 (301293.SZ)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/301293.SZ.md" symbol: "301293.SZ" name: "三博脑科医院管理集团股份有限公司" industry: "医疗机构" --- # 三博脑科医院管理集团股份有限公司 (301293.SZ) | Item | Detail | |------|--------| | Industry | 医疗机构 | | Location | 沪深市场 | | Website | [www.sbnkjt.com](https://www.sbnkjt.com) | ## Company Profile 公司于 2003 年由神经医学专家栾国明、于春江、石祥恩及资深医疗管理专家张阳等人创建,经过二十年发展,探索出一套全新的医院管理模式,形成了以医疗投资、医院管理、品牌运营为主导,以 “博医、博教、博研” 为愿景,集 “医疗、教学、科研” 于一体的医疗集团。公司的主营业务是为患者提供医疗服务。 ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-21T04:30:10.000Z **Overall: B (0.36)** **Industry**: Health Care Facilities | Metric | Value | |--------|-------| | Industry Ranking | 2 / 9 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 16.75% | | | Net Profit YoY | -23.29% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 7.02 | | | Dividend Ratio | 0.18% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 16.41B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 1.64B | | **Multi Score**: B #### Profit Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 3.63% | C | | Profit Margin | 5.12% | C | | Gross Margin | 22.72% | D | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 16.75% | B | | Net Profit YoY | -23.29% | D | | Total Assets YoY | 24.85% | A | | Net Assets YoY | 5.23% | B | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 1954.56% | A | | OCF YoY | 16.75% | B | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.49 | C | #### Debt Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 29.57% | B | ```chart-data:radar { "title": "Longbridge Financial Score - 三博脑科医院管理集团股份有限公司", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "C", "indicators": [ { "name": "ROE", "value": "3.63%", "rating": "C" }, { "name": "Profit Margin", "value": "5.12%", "rating": "C" }, { "name": "Gross Margin", "value": "22.72%", "rating": "D" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "16.75%", "rating": "B" }, { "name": "Net Profit YoY", "value": "-23.29%", "rating": "D" }, { "name": "Total Assets YoY", "value": "24.85%", "rating": "A" }, { "name": "Net Assets YoY", "value": "5.23%", "rating": "B" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "1954.56%", "rating": "A" }, { "name": "OCF YoY", "value": "16.75%", "rating": "B" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.49", "rating": "C" } ] }, { "name": "Security", "grade": "B", "indicators": [ { "name": "Gearing Ratio", "value": "29.57%", "rating": "B" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 爱尔眼科 (SZ.300015) | B | C | B | B | C | B | | 02 | 三博脑科 (SZ.301293) | C | B | C | B | B | B | | 03 | 盈康生命 (SZ.300143) | C | B | C | B | B | B | | 04 | 华厦眼科 (SZ.301267) | B | C | C | B | C | C | | 05 | 创新医疗 (SZ.002173) | D | D | C | A | D | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 195.15 | 4/9 | 144.45 | 111.38 | 88.43 | | PB | 7.02 | 7/9 | 5.45 | 4.84 | 4.16 | | PS (TTM) | 9.98 | 8/9 | 8.15 | 7.27 | 6.54 | | Dividend Yield | 0.18% | 3/9 | 0.25% | 0.22% | 0.16% | ## References - [Company Overview](https://longbridge.com/en/quote/301293.SZ/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/301293.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/301293.SZ/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.